Their blockade results in the removal of inhibitory signals of T-cell activation, enhancing anti-tumor immune activity and leading to the inhibition of tumor growth, through CD8+ T-cell mediated cancer cells death [150,151]. The gene discussed is CD8A; the disease is neoplasm.